U.S. FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA could help create several international coalitions to carry out its new globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors